STUB1 and hydrops fetalis: In marked contrast, for both VAF ≥ 2% and VAF < 2%, CHIP mutations were much more prevalent in healthy middle-aged individuals in the AWHS cohort and in elderly HF patients than in HGPS patients (Table 1, Supplementary Table S3).